Loading data
PATHNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.61 bn USD | 1.43 bn USD | 1.31 bn USD | 1.06 bn USD | 892.25 m USD |
| Cost of revenue | 270.98 m USD | 246.94 m USD | 195.92 m USD | 180.05 m USD | 168.87 m USD |
| Gross profit | 1.34 bn USD | 1.18 bn USD | 1.11 bn USD | 878.53 m USD | 723.38 m USD |
| Research and development expense | 385.21 m USD | 380.68 m USD | 332.1 m USD | 285.75 m USD | 276.66 m USD |
| Operating profit | 56.76 m USD | -162.57 m USD | -164.72 m USD | -348.28 m USD | -500.95 m USD |
| Profit before tax | 100.63 m USD | -78.1 m USD | -75.82 m USD | -317.56 m USD | -510.88 m USD |
| Income tax expense | -181.7 m USD | -4.41 m USD | 14.07 m USD | 10.79 m USD | 14.7 m USD |
| Net income (reported basis) | 282.33 m USD | -73.69 m USD | -89.88 m USD | -328.35 m USD | -525.59 m USD |
| Basic earnings per share | 0.52 USD/share | -0.13 USD/share | -0.16 USD/share | -0.6 USD/share | -1.16 USD/share |
| Diluted earnings per share | 0.52 USD/share | -0.13 USD/share | -0.16 USD/share | -0.6 USD/share | -1.16 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.